Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-01-07 @ 2:22 PM
Study NCT ID:
NCT03163667
Status:
COMPLETED
Last Update Posted:
2022-09-15
First Post:
2017-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)
Sponsor:
Calithera Biosciences, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CX-839-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None